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Abstract To examine the role of Rho GTP binding proteins in 
the adhesion of monocytic cells to fihronectin we used the C3 
exoenzyme of Clostvidium botulinurn which ADP-ribosylates and 
inactivates Rho proteins in situ. Treatment of human monocytic 
U937 cells with C3 exoenzyme (10 pglml, 24 h) increased adhe- 
sion to fibronectin 2-fold but had no effect on adhesion to collagen 
or human serum albumin. The increase in fibronectin adhesion 
was prevented by antibodies against the cu5 and jjl integrin sub- 
units, but surface expression of pl and ct5 was not altered. These 
results suggest that Rho proteins regulate the interaction of the 
monocyte cy5j.31 integrin receptor with fibronectin by post recep- 
tor mechanisms. 
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1. Introduction 
Ras-related Rho GTP binding proteins have been implicated 
in the organisation of the actin cytoskeleton and in the assem- 
bly and activity of integrin receptors [l]. These functions of Rho 
proteins have been established mainly by use of the C3 exoen- 
zyme of Clostridium botulinurn which specifically ADP-ribosyl- 
ates and thereby inactivates Rho (A, B and C) in intact cells, 
presumably by blocking its interaction with downstream targets 
[2%]. Evidence that Rho is involved in integrin function comes 
from the finding that C3 exoenzyme blocked formation of focal 
adhesion sites in quiescent fibroblasts stimulated by the growth 
factors PDGF and lysophosphatidic acid and that, vice versa, 
microinjection of activated Rho stimulated focal adhesion for- 
mation [6]. At focal adhesion sites, intracellular actin fibers are 
connected to extracellular integrin receptors via multimolecular 
regulatory complexes at the plasma membrane [7]. Further 
reports implicating Rho in integrin function showed that ADP- 
ribosylation of Rho inhibited LFA-l-dependent lymphocyte 
aggregation [S] as well as thrombin-induced platelet aggrega- 
tion mediated by the glycoprotein IIb-IIIa [9]. 
Here the effect of ADP-ribosylation of Rho on fibronectin 
receptor function was examined. For this purpose we took 
advantage of the human myelomonocytic U937 cell line which 
adheres to fibronectin through the a5gl and a4pl integrin 
receptors [lo], but does not adhere to a variety of other extracel- 
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Abbreviations; LFA, lymphocyte function antigen; C3, C3 exoenzyme 
from Clostridium botulinurn; MFI, mean fluorescence intensity. 
lular matrix proteins tested ([l 11, and this study). We demon- 
strate that ADP-ribosylation of Rho in monocytic U937 cells 
results in an enhanced adhesion to fibronectin which is medi- 
ated by the cl5bl fibronectin receptor. 
2. Materials and methods 
2.1. Materials 
The pGEX2TC3 exoenzyme expression vector was a generous gift 
from Dr. L. Feig (Tufts University, Boston, USA). Rabbit polyclonal 
anti-RhoA was purchased from IC Chemikalien (Ismaning, Germany) 
and tested with the recombinant glutathione S-transferase fusion prb- 
tein of RhoA, Racl and CDC42Hs 1121. on Western blot. Mouse mon- 
oclonal anti-a5 (clone PlD6) and /3l (clone P4ClO) were from Gibco 
(MD, USA), FITC-conjugated rat anti-mouse IgG was from Serotec 
(Oxford, UK) and horseradish peroxidase conjugated anti-rabbit IgG 
was from Amersham. RPM1 1640, r-glutamine, fetal calf serum and all 
other materials were from Sigma. 
2.2. Preparation of recombinant C3 exoenzyme 
The C3 exoenzyme was expressed as a glutathione Stransferase 
(GST) fusion protein in E. coli strain NM522. Expression of the fusion 
protein was induced by isopropylthiogalactopyranoside (Boehringer, 
Mannheim, Germany), bacteria were lysed by sonication and the fusion 
protein was purified with glutathione-Sepharose 4B beads (Pharmacia, 
Sweden) and cleaved with thrombin (Boehringer, Mannheim, Ger- 
many) as described in detail [13]. Purity of the C3 exoenzyme was tested 
on SDS/12% PAGE and protein concentration was determined with the 
BCA method (Pierce, Rockford, IL, USA) using BSA as the standard. 
2.3. Cell culture and C3 exoenzyme treatment 
U937 cells, a gift from Dr. C. Wilson (Children’s Orthopedic Hospi- 
tal, University of Washington, Seattle, WA), were grown in RPM1 1640 
with 2 mM L-glutamine and 10% fetal calf serum at 37°C in a humid- 
ified 5% CO, atmosphere. Cultures were maintained for 72 h in 80 cm’ 
culture flasks (Falcon, Becton Dickinson), centrifuged (150 x g, 5 min) 
and resuspended at a density of 2 x lo5 cells/ml in fresh medium with 
or without C3 exoenzyme. Cell viability was determined by ethidium 
bromide/Acridine orange fluorescence and was > 90% in the absence or 
presence of C3 exoenzyme. 
2.4. [3’P]ADP-ribosylation and SDS-PAGE 
Cells were pelleted by centrifugation (150 x g, 5 min), washed once 
in PBS, resuspended at 2 x 106/ml in ice-cold buffer containing 250 mM 
sucrose, 1 mM EDTA, 5 mM MgCl,, 10 mM HEPES (pH 7.4), 1 mM 
dithiothreitol, 0.1 mM GTP; 1 &ml of leupeptin, pepstatin, aprotinin, 
and 2 mM phenylmethylsulfonyl fluoride (PMSF) and soniiated for 
10 s at 50 W with a Labsonic U (B. Braun, Melsungen. Germany). 100 
~1 of this homogenate was added to 50 ~1 of 150 mM Tris-HCI YpH 8) 
30 mM thymidine, 3 mM dithiothreitol, 5 mM MgCI,, 0.3 mM GTP 
and 0.5 pg of recombinant C3 exoenzyme on ice. The reaction was 
started by adding 1 PCi [‘*PI NAD (800 Ci/mmol, NEN) to the sample; 
then it was incubated for 15 min in a 37°C waterbath and precipitated 
for 45 min at -20°C with 6 ~01s. of ice-cold acetone. Precipitates were 
analyzed by SDS-12% PAGE (Mini-Protean II; Bio-Rad) and autoradi- 
ography using Kodak X-OMAT films. Bands were quantified by laser 
densitometry (Ultroscan XL; Pharmacia, Freiburg, Germany) using 
peak area integration according to manufacturers instructions (Phar- 
macia). Bands were only evaluated when their density was within the 
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linear part of a standard curve obtained by [3*P]ADP-ribosylating serial 
dilutions of recombinant RhoA (100 ng, 30 ng, 10 ng, 1 ng and 0.3 ng). 
2.5. Western blot 
After SDS-12% PAGE (Mini Protean II; Bio-Rad), proteins were 
electrophoretically transfered to Immobilon PVDF membranes (Mil- 
lipore, MA, USA) for 1 h at 80 V in 20 mM Tris, 192 mM glycine. 
Membranes were blocked for 1 h in a solution containing 20 mM 
Tris-HCl, pH 7.4, 150 mM NaCl, 0.3% Tween, 10% calf serum; then 
they were incubated for 1 h with anti-RhoA antibody (1: 2000). After 
incubation for 45 min with peroxidase-labeled anti-rabbit IgG 
(1:5000), blots were developed using ECL (Amersham) and 
then exposed to X-Omat AR film (Kodak). 
2.6. Cell adhesion assay 
Cells were washed in PBS, resuspended at lo6 cells/ml in RPM1 
medium containing 1% human serum albumin and 100~1 per well was 
added to a 96-well microtiter plate (Falcon) that had been precoated 
overnight at room temperature with 100~1 of lOpg/ml fibronectin from 
human plasma, lOO&ml collagen G (90% collagen I, 10% collagen III; 
Biochrom, Berlin, Germany) or 1 mg/ml human serum albumin. Cells 
were incubated for 1 h at 37°C and non-adherent cells were removed 
by centrifugation of the inverted microtiter plate for 3 min at 200 x g. 
Pretreatment with antibodies was performed for 1 h at 4°C using 10 
@/ml anti-a5 or 10 @ml anti-/?1 antibodies. For quantification of 
adherent cells 150 ~1 of RPM1 and 15 ~1 of MTT (5 mg/ml) was added, 
incubated for 4h at 37°C and cells were lysed with 100 ~1 of 15% SDS 
in 15 mM HCl per well. After overnight incubation at room tempera- 
ture, plates were read at 570 nm in an ELISA reader and the number 
of adherent cells was calculated using calibration curves obtained with 
known amounts of cells. 
2.7. FACS-analysis 
Cells (2 x 10’ in 200 ~1) were incubated for 30 min at 4°C in phos- 
phate-buffered saline with 10 pllml anti-a5 or IgG, isotype control or 
10 @/ml anti-/I1 or IgG, isotype control, washed in PBS and then 
incubated for 1 h at 4°C with a 1:40 dilution of FITC-conjugated rat 
anti-mouse IgG. Samples were washed and analyzed at lo4 cells per 
sample in a FACSscan (Becton Dickinson). AMFI is defined as the 
difference in the mean fluorescence intensities of signals obtained with 
anti-integrin antibodies and their isotype controls. 
3. Results and discussion 
To detect the Rho ADP-ribosylation substrate in U937 cells 
we incubated whole cell homogenate with C3 ADP-ri- 
bosyltransferase from Clostridium botulinurn and [32P]NAD. 
SDS-PAGE and autoradiography revealed one [32P]ADP-ri- 
bosylated band at 23 kDa that co-migrated with RhoA on a 
[=P]ADP Rho A 
Fig. 1. Autoradiography of the [“P]ADP-ribosylation substrate and 
RhoA immunoblot in U937 cells. Control and C3-pretreated (24h, 10 
&ml) U937 cells were homogenised, incubated with [3*P]NAD and 
recombinant C3 exoenzyme and subjected to SDS-12.5% PAGE and 
either autoradiography (left panel) or immunoblot using specific anti- 
RhoA antibody (right panel). 
Fibronectin HSA Collagen 
Fig. 2. Effect of C3 exoenzyme on fibronectin adhesion of U937 cells. 
Cells were pretreated without (Control) or with C3 exoenzyme (24 h, 
10 fig/ml) and then adhesion to fibronectin, human serum albumin 
(HSA) or collagen was tested (section 2). Each bar represents the 
mean f S.D. of three experiments. *Indicates P c 0.01. 
Western blot (Fig. 1, Controls). When intact U937 cells were 
pretreated with C3 (10 pg, 24 h), in vitro incorporation of 
[32P]ADP into the substrate was diminished to 20-30% of con- 
trol (Fig. 1, left panel), suggesting that 70-80% of Rho was 
ADP-ribosylated in situ. The total cellular amount of the Rho 
ADP-ribosylation substrate was not altered by the C3 treat- 
ment as demonstrated by anti-RhoA Western blot (Fig. 1, right 
panel). No protein band was found with anti-RhoB antibody 
(data not shown). The ADP-ribosylation substrate in U937 
cells most likely is RhoA: (i) on a two-dimensional gel it co- 
migrated with RhoA detected by Western blot (Aepfelbacher 
et al., unpublished) and (ii) it co-migrated with the ADP-ri- 
bosylation substrate in platelets that was identified as RhoA 
[14]. Consistent with these findings, RhoA seems to be the 
major ADP-ribosylation substrate in most cells investigated so 
far, including mouse fibroblasts [15], human blood platelets 
[ 141, lymphocytes [ 161, neuronal cells [ 171, and myelomonocytic 
HL60 cells (Aepfelbacher et al., submitted). Taken together 
these data suggest that the C3 from Clostridium botulinurn 
ADP-ribosylates a protein in intact U937 cells that most likely 
is RhoA. 
To test the effect of ADP-ribosylation of Rho on fibronectin 
adhesion of U937 cells we incubated control- and C3-treated 
cells in fibronectin-coated culture dishes (1 h, 37°C) and re- 
moved non-adherent cells by centrifugation. The percentage of 
cells that adhered to fibronectin increased from approximately 
Table 1 
Effect of C3 exoenzyme on surface expression of the a5 and /ll integrin 
subunits 
Integrin subunit AMFI 
Control c3 
872 13 84 f 2 
81 f 8 91 t7 
U937 cells were treated for 24 h without (control) or with 10 &ml C3 
exoenzyme. AMFI (difference in mean fluorescence intensity) was de- 
termined for each integrin subunit by FACS analysis as described in 
section 2. Each value represents the mean f SD. of three experiments 
performed in duplicate. 
80 M. Aepfelbacherl FEBS Letters 363 (1995) 78-80 
h 
t-9 
0 
r 
x El Control 
cn 
= 
6 50 
5 
G 
6 
a 
0 
+ a5 +Pl 
Fig. 3. Effect of anti-a5 and -/?l antibodies on fibronectin adhesion of 
control and C3-treated U937 cells. Cells were treated without (Control) 
or with C3 exoenzyme (24 h, IO pg/ml) preincubated (1 h, 4°C) with 
vehicle (0) or indicated antibodies and tested for adhesion to fi- 
bronectin (section 2). Each bar represents the mean f SD. of three 
experiments. 
45% in controls to 90% after C3 treatment (Fig. 2). Less than 
5% of cells adhered to collagen or human serum albumin with 
or without C3 treatment. These data confirm the observation 
that U937 cells only adhere to fibronectin and not to a variety 
of other extracellular matrix proteins [l l] and suggest that the 
increased adhesion of C3-treated U937 cells is fibronectin re- 
ceptor dependent. 
U937 cells adhere to fibronectin mainly via the c@l and to 
a lesser extent via the a4jIl receptor [lo]. To identify the inte- 
grin receptors that mediated the enhanced adhesion to fi- 
bronectin in C3-treated cells, we preincubated cells with block- 
ing antibodies against the a5 and /I1 subunits. The anti-a5 
antibody PlD6 completely prevented the increase in fibronectin 
adhesion in C3-treated cells and slightly reduced the percentage 
of control cells adhering to fibronectin (Fig. 3). In comparison, 
the anti-j?1 antibody P4ClO also prevented the C3 induced 
increase in fibronectin adhesion but markedly reduced the per- 
centage of control cells adhering to fibronectin (Fig. 3). Hence, 
the increased fibronectin adhesion in C3-treated cells seems to 
be mediated entirely by the a5pl integrin whereas basal fi- 
bronectin adhesion seems to involve an additional a subunit, 
most likely a4. 
To investigate the possibility that the increased fibronectin 
adhesion in C3 treated cells was due to up-regulation of the 
as/?1 fibronectin receptor, we performed FACS analysis using 
specific anti-a5 and anti+1 antibodies. Surface expression of 
neither integrin subunit was affected by the C3 treatment, as 
evidenced by the unchanged differences in the mean fluores- 
cence intensities (dMF1) between control and C3-treated cells 
(Table 1). 
In summary, our data provide evidence that ADP-ribosyla- 
tion of Rho GTP binding proteins increases adhesion of human 
monocytic U937 cells to fibronectin via the as/?1 integrin. 
Recent studies using different cell types suggested that blocking 
of Rho proteins by ADP-ribosylation resulted in inhibition 
rather than stimulation of integrin function [6,8,14]. However, 
the functions of Rho proteins might be cell type specific. For 
example, in neuronal cells ADP-ribosylation of Rho leads to 
cell flattening and neurite outgrowth [ 171, whereas in Vero and 
3T3 cells it causes cell rounding and loss of contact with the 
extracellular matrix [ 1,2]. 
A recent study demonstrated that in myelomonocytic cells 
ADP-ribosylation of Rho resulted in enhanced actin polymeri- 
sation after cell stimulation [ 181. Considering that actin polym- 
erisation has been implicated in integrin dependent adhesion of 
leukocytic cells to the extracellular matrix [19], it is possible that 
this or a related phenomenon may be responsible for the in- 
creased fibronectin adhesion of C3-treated U937 cells observed 
in our study. 
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